(Q82892161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

acute myeloid leukemia

1 reference

A Tsuboi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Y Oka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

T Kyo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Y Katayama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

O A Elisseeva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Kawakami

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Nishida

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Morimoto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Murao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Nakajima

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N Hosen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Y Oji

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Sugiyama

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

13 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1410-1413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157809%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.343

18 January 2020

exact match

0 references

cites work

WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021

Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8+ T cells in patients with myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.343

7 January 2021